Medicine reading guide
Rosuvastatin
Crestor conventional oral tablets; US prescribing information. Other formulations require their own instructions.
How it works
Rosuvastatin slows an enzyme in the liver that helps make cholesterol. The liver responds by putting more LDL-catching receptors on its cells, removing more LDL cholesterol from the blood. Lowering LDL over time reduces a contributor to artery disease. It does not dissolve a blood clot or provide immediate treatment for chest pain.
Original content record dated 2026-09-30. Educational draft; independent clinical review pending.
About the referenced label
Selected label version 19 · SPL effective date 2026-09-23 · Retrieved 2026-10-09.
Label record supplied by AstraZeneca Pharmaceuticals LP. This may be a repackager's record.
These dates describe the source record, not a clinical review of this explanation. The online label may change; this explanation has not been revalidated against the retained snapshot by this source check.
Uses / Symptoms
- High LDL cholesterol
- Cardiovascular risk reduction when indicated
Effects
- Lowers LDL cholesterol
- Reduces cardiovascular events in eligible groups
Side effects
- Muscle pain or weakness
- Headache, nausea or abdominal pain
- Serious: muscle breakdown or liver problems
Selected uses and effects; not a complete safety list. Consult the referenced product information.
Explore the Rosuvastatin mechanism GIF and named chapters →
Questions about Rosuvastatin
What is this medicine used for?
Rosuvastatin lowers LDL cholesterol and is prescribed to reduce cardiovascular risk in appropriate patients. It is used alongside diet and other risk-reduction measures. Crestor is labeled to reduce major cardiovascular events in adults at increased risk and to treat several lipid disorders. Pediatric use is restricted to specified inherited disorders and age ranges.
Why might it be prescribed for me?
Rosuvastatin may be chosen when LDL lowering or cardiovascular risk reduction is indicated. The decision depends on previous cardiovascular disease, lipid results, overall risk, interactions, and tolerance. It is not prescribed only because someone feels ill. For an individual, kidney or liver disease, other medicines, and pregnancy plans can change the choice or dose.
What improvement should I expect?
Rosuvastatin can lower LDL cholesterol even when you feel no different. In appropriate groups, clinical trials also show fewer cardiovascular events. The size of personal benefit depends on baseline cardiovascular risk, the dose, adherence, and duration. A lower cholesterol result is evidence of biological response; it does not guarantee that an individual will never have a heart attack or stroke.
How soon should it start working?
Rosuvastatin does not usually produce a sensation that tells you it is working. Follow the LDL cholesterol measurement: the label supports checking from about 4 weeks after initiation or adjustment. Maximum LDL reduction is generally reached by 4 weeks and maintained with continued treatment. If the result is disappointing, review adherence and the regimen before assuming treatment failure.
How will I know whether it is helping?
Follow LDL cholesterol to assess rosuvastatin response and adherence, with an early check possible from 4 weeks. Consider liver tests before treatment and thereafter when clinically indicated. Muscle pain or weakness may prompt CK testing and clinical evaluation. Persistent unexplained protein or blood in urine deserves evaluation; severe kidney impairment requires dose restrictions. Monitoring is tailored to symptoms and risk, not a universal monthly panel.
How does it work, in simple terms?
Rosuvastatin slows an enzyme in the liver that helps make cholesterol. The liver responds by putting more LDL-catching receptors on its cells, removing more LDL cholesterol from the blood. Lowering LDL over time reduces a contributor to artery disease. It does not dissolve a blood clot or provide immediate treatment for chest pain.
How much is usually taken, and how often?
For Crestor tablets, the labeled adult range is 5–40 mg once daily. Starting dose depends on risk, LDL reduction needed, kidney function, ancestry-related exposure, and interacting medicines. Severe renal impairment has a lower maximum. Children have separate indication-specific regimens. These are label ranges, not an individual recommendation; statins are not interchangeable milligram-for-milligram.
Should I take it with food?
Take Crestor tablets once daily at a consistent time, with or without food. Morning or evening is acceptable for this product. Swallow Crestor tablets whole. If using an aluminum/magnesium hydroxide antacid, take Crestor at least 2 hours before the antacid. Ask before altering a tablet for swallowing or feeding-tube problems.
What should I do if I miss a dose?
The current Crestor tablet label says to skip a missed dose and take the next dose at the usual scheduled time. Do not take an extra dose to catch up. If a dose may already have been taken, check the record before repeating it. For an accidental extra dose, contact a pharmacist or Poison Help rather than improvising the next schedule.
What if I accidentally take too much?
If too much rosuvastatin was taken, contact US Poison Help at 1-800-222-1222 or seek medical advice promptly, even if there are no symptoms yet. Have the product, strength, amount, and time available. Call emergency services for collapse, seizure, trouble breathing, or inability to wake. There is no specific antidote in the label; treatment is supportive, and dialysis does not meaningfully improve clearance.
How long might treatment continue?
Rosuvastatin is usually preventive treatment over the long term rather than a short course. Reassess LDL response after starting or changing treatment; the label permits assessment as early as 4 weeks. Whether to continue depends on cardiovascular risk, response, tolerability, and preferences. A normal cholesterol result while taking it does not by itself mean the underlying tendency has disappeared.
Can I stop when I feel better?
Feeling well is expected during preventive treatment with rosuvastatin; it is not a reason by itself to stop. The label does not prescribe a taper. Arrange a plan with the prescriber if treatment needs changing, because LDL lowering will not persist indefinitely after withdrawal. Suspected serious muscle injury, serious liver injury, or pregnancy requires prompt clinical review rather than routine self-directed continuation.
What side effects are common?
Rosuvastatin can cause muscle symptoms and digestive symptoms; reported effects do not all prove the drug was responsible. Crestor trials reported headache, muscle pain, abdominal pain, nausea, and weakness; serious muscle breakdown can occur. Blood glucose can rise in some people. Report troublesome symptoms so the regimen can be reviewed rather than abandoning cardiovascular prevention without an alternative.
Which symptoms need urgent help?
Seek prompt assessment for unexplained muscle pain or weakness, especially with fever, marked illness, dark urine, or reduced urine. Yellow skin or eyes and severe fatigue can indicate liver injury. Severe allergic symptoms such as facial swelling or trouble breathing need emergency care. Chest pain or stroke symptoms require emergency evaluation regardless of whether rosuvastatin is being taken.
Can it interact with medicines or supplements?
Rosuvastatin has important transporter-mediated interactions despite limited CYP metabolism. Cyclosporine, gemfibrozil, several antivirals, and other drugs require avoidance or dose limits. Warfarin requires INR monitoring when rosuvastatin is started, changed, or stopped. Aluminum/magnesium hydroxide antacids should be taken at least 2 hours after Crestor. Have a pharmacist check supplements and the full prescription list.
What about alcohol, driving, and exercise?
Exercise and a cholesterol-lowering eating pattern remain part of care with rosuvastatin. Report new unexplained muscle symptoms rather than assuming exercise caused them. Substantial alcohol consumption increases concern about liver injury; discuss your pattern with the clinician. There is no universal label-based driving ban, but do not drive if you personally feel unwell or impaired.
What about pregnancy, breastfeeding, or fertility?
Contact the prescriber promptly if pregnancy occurs while taking rosuvastatin. The label advises discontinuation when pregnancy is recognized, while allowing consideration of unusual ongoing therapeutic needs. Treatment is usually paused because lipid lowering is rarely needed during pregnancy. Breastfeeding is not recommended during treatment. This is not evidence that accidental early exposure inevitably harms a baby; individual review is appropriate. A fertility effect has not been established in this review.
Will I need tests or monitoring?
Follow LDL cholesterol to assess rosuvastatin response and adherence, with an early check possible from 4 weeks. Consider liver tests before treatment and thereafter when clinically indicated. Muscle pain or weakness may prompt CK testing and clinical evaluation. Persistent unexplained protein or blood in urine deserves evaluation; severe kidney impairment requires dose restrictions. Monitoring is tailored to symptoms and risk, not a universal monthly panel.
Is there a generic or a lower-cost option?
Rosuvastatin is the generic drug name; Crestor is a brand of tablets. It is a prescription medicine in the US. The lowest cost depends on the pharmacy, strength, quantity, insurance, and local availability, which have not been checked here. Ask the pharmacist for the cost of an appropriate generic and arrange refills before the supply runs out.
What if it is not helping?
If rosuvastatin is not meeting the treatment goal, first review the actual dose, regular use, interactions, and LDL result. The clinician may change statin dose or product or consider another cholesterol-lowering treatment. A switch depends on cardiovascular risk and the reason for changing. This review does not identify one universally best substitute or establish current insurance coverage.